AKAyhan Gazi Kalaycı

Ayhan Gazi Kalaycı

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ayhan Gazi Kalaycı has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fecal calprotectin levels used as a noninvasive method for screening for chronic gastritis in pediatric patients. A descriptive study

    by Fatma Demirbaş, Gönül Çaltepe, Hasan Abbasguliyev, Ayhan Gazi Kalaycı

    BACKGROUND: Gastritis consists of inflammation of the gastric mucosa and is one of the main causes of dyspeptic symptoms in children. OBJECTIVE: To investigate the presence of inflammation by evaluating fecal calprotectin (FC) in children diagnosed with chronic gastritis. DESIGN AND SETTING: Descriptive study in Pediatric Gastroenterology Department of Ondokuz Mayis University Hospital in Turkey. METHODS: Between January 2016 and July 2018, FC levels were compared retrospectively in children with chronic gastritis (histopathology-based diagnosis), patients with inflammatory bowel disease (IBD) and healthy children. RESULTS: A total of 67 chronic gastritis patients (61.2% girls) with a mean age of 13.09 +/- 3.5 years were evaluated. The mean FC levels were 153.4 mu g/g in the chronic gastritis group, 589.7 mu g/g in the IBD group and 43.8 mu g/g in the healthy group. These levels were higher in chronic gastritis patients than in healthy individuals (P = 0.001) and higher in IBD patients than in the other two groups (P < 0.001). The FC level in the patients with chronic active gastritis (156.3 mu g/g) was higher than in those with chronic inactive gastritis (150.95 mu g/g) (P = 0.011). Among the patients with chronic active gastritis, the FC level was significantly higher in Helicobacter pylori-positive individuals than in negative individuals (P = 0.031). CONCLUSION: We confirmed the association between increased FC and chronic gastritis. Elevated FC levels may be seen in patients with chronic active gastritis. In order to be able to use FC as a screening tool for chronic gastritis, further studies in a larger study group are needed.


  • Çölyak Hastalığının Genetik Allel Dağılımının Değerlendirilmesi ve Türkiye Literatür Taraması

    by Fatma Demi̇rbaş, Aslıhan SANRI, Gönül Di̇nler Çaltepe, Atakan Comba, Ayhan Gazi Kalayci

    Amaç: Çölyak hastalığı (ÇH), genetik yatkınlığı olan bireylerde, glutene kalıcı duyarlılık sonucu gelişen, otoimmün, sistemik hastalıktır. Bu çalışmanın amacı, ÇH’nin klinik, laboratuar özellikleri ve HLA doku tiplerinin geriye dönük değerlendirilmesidir.Ayrıca lieratür taramasıyla HLA doku tipleri açısından Türkiye’de bölgelere göre farklılık ve benzerliklerin incelenmesidir. Yöntem: Çalışmaya, Temmuz 2017- Ekim 2018 tarihleri arasında ÇH tanısıyla izlenen ve genetik çalışması uygulanan 104 çocuk alındı. Google Scholarda Türkiye’de ÇH ve HLA genotiplendirme ile yapılan çalışmalar tarandı (n=11 çalışma) ve bölgelere ayrıldı. Bulgular: Çalışmaya alınan 104 hastanın 67’si kız (%64,4) ve ortalama tanı yaşı 7,9±2,38 yıl(10ay-17,2yıl) idi. Hastalarımızın HLA grupları %59,6 DQ2, %26,9 DQ8 ve %13,4 DQ2+DQ8 saptandı. Literatürdeki çalışmalar bölgeler göre değerlendirildiğinde bizim de içinde bulunduğumuz Karadeniz bölgesinde HLADQ2 %63,7 ve HLADQ8 %21,1 sıklıkla görülürken, bölgemize benzer oranlarda genotip sıklığı Akdeniz ve Doğu Anadolu bölgelerinde görülmektedir. İç Anadolu HLADQ2 %87,4 ve Marmara bölgesinde %83,6 ile daha yüksek frekansta görülmektedir. Çalışmamızda, DQA1*05 %65,4 ve DQB1*02 %12,5 oranında bulundu. Türkiye’deki diğer çalışmalarda (Marmara, Karadeniz, İç, Doğu ve Güneydoğu Anadolu Bölgeleri) görülme sıklığı DQA1*05%69,8 ve DQB1*02 %27,7 idi. Çalışmamızda HLA DQB1*02 homozigot olan hastalarda (%12,5) boy kısalığı, ishal, demir eksikliği anemisi, Marsh3 evre ve akrabalarında ÇH daha yüksekti. Sonuç: Çölyak hastalığında HLA-DQ analizi bölgesel sıklığın belirlenmesi genetik analiz maliyetini azaltmak ve bölgesel dağılıma göre özellikle semptomsuz tarama hastalarında genotiplenme yapılması erken tanı kolaylığı sağlayabilir.


  • Open Access

    Endoscopic Ultrasonography in Pediatric Patients with Pancreatobiliary Disease: Single-Center Trial

    by Fatma Demirbaş, Mustafa Kaymazlı, Gönül Çaltepe, Hasan Abbasguliyev, Ayhan Gazi Kalaycı, Ahmet Bektaş

    Demirbaş F, et al. Pediatr Gastroenterol Hepatol Nutr. 2021 Mar;24(2):164-172. https://doi.org/10.5223/pghn.2021.24.2.164


  • Pre- and Postgastrostomy Evaluation of Gastroesophageal Reflux in Children Using 24-Hour pH Monitoring

    by Fatma Demirbaş, Berat Dilek Demirel, Gönül Çaltepe, Hasan Abbasguliyev, Rıza Ferit Bernay, Ayhan Gazi Kalayci

    Background: The aim of this study was to evaluate 24-hour pH monitoring results before and after gastrostomy in neurological impaired (NI) children who underwent gastrostomy or Nissen fundoplication (NF) concurrently with gastrostomy. Materials and Methods: Between March and December 2018, NI patients who had previously received pre- and postgastrostomy (Group 1) or gastrostomy + NF (Group 2) underwent pH monitoring pre- and postoperatively. Results: Twenty patients [12 males (60%) and the median age of 5.6 (14 months–14.7 years) years] with NI were followed up during the study period. When pre- and postgastrostomy weight and BMI z-scores were compared, the results were significantly higher in both groups after procedure (P = .043, P = .040, respectively). The clinical results of the patients after the operation showed improvement in both groups. The pH index of Group 1 (n = 11) was 2.32 (0–3.8) before gastrostomy and 3.18 (2.1–6.9) after gastrostomy (P = .061) and in Group 2 (n = 9) it was 5.85 (4.9–15.8) and 0.61 (0.3–1.3), before and after procedure (P < .001). There was a statistically significant difference in reflux index of each group. This difference was not statistically significant between the groups (P = .072). When the total bolus exposure index was compared, it was 4.01 (2.1–5.2) before gastrostomy and 5.67 (4.6–6.3) after gastrostomy in Group 1 (P = .041). In group 2, that index was found to be 9.8 (8.3–10.2) before and 1.28 (0.5–1.4) after (P < .001). There was a statistically significant difference in index after gastrostomy in Groups 1 and 2 (P = .023). Conclusions: Gastrostomy feeding is an effective and safe option to achieve enteral feeding in NI children. NF concurrent with gastrostomy should be decided according to the individual patient. Clinical trials protocol registration ID number was PRS NCT 0445112.


  • Association of obesity and non-alcoholic fatty liver disease with the fecal calprotectin level in children

    by Fatma Demirbaş, Gönül Çaltepe, Atakan Comba, Hasan Abbasguliyev, Neval Yurttan Uyar, Ayhan Gazi Kalaycı


  • Diagnostic Challenges of Wilson Disease in Early Childhood

    by Fatma Demirbaş, Ayça Efendioğlu Ağayev, Gönül Çaltepe, Ayhan Gazi Kalaycı


  • Fecal calprotectin in children with familial Mediterranean fever in the attack‐free period

    by Fatma Demirbaş, Gönül Çaltepe, Atakan Comba, Hasan Abbasguliyev, Neval Yurttan Uyar, Ayhan Gazi Kalaycı

    Background Familial Mediterranean Fever (FMF) is an autosomal recessive disease characterized by reccurent episodes of fever and serosal inflammation. The aim of this study was to evaluate fecal calprotectin (FC) levels of children with FMF during the non‐attack period. Methods A retrospective evaluation was made of the data of a total 66 patients diagnosed with FMF in an attack‐free period and without amyloidosis/IBD. The FC levels of the patients were compared with the FC levels of patients with IBD and healthy control subjects. Results The FMF patients comprised of 37 (56.1%) males with a mean age of 10.1 ± 3.9 years (range, 5‐17.9 years). The FC levels were determined as 192.5 (19.5‐800) μg/g in the FMF group, 597.9 (180‐800) μg/g in the IBD group, and 43.8 (19.5‐144) μg /g in the control group. The FC level of the children with FMF was higher than that of the control group (P < 0.001), and the FC level of the IBD patients was found to be higher than both of the FMF and the control groups (P = 0.020, P < 0.001, respectively). Conclusions The results of the study showed that the FC levels were higher in FMF patients compared to healthy children even in the absence of IBD/amyloidosis. Even though colonoscopy is the gold standard in determining intestinal inflammation in FMF patients, a non‐invasive and inexpensive method FC can be used for screening. This study indicated the presence of subclinical intestinal inflammation quantitatively in children with FMF.